RUSSELL FRANK CO/ - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$67,000
-96.9%
11,800
-90.0%
0.00%
-100.0%
Q3 2015$2,188,000
+168.1%
118,443
+182.4%
0.00%
+300.0%
Q2 2015$816,000
+31.0%
41,946
+18.4%
0.00%0.0%
Q1 2015$623,000
+299.4%
35,441
+276.9%
0.00%
Q3 2013$156,000
+64.2%
9,403
-0.2%
0.00%
Q2 2013$95,0009,4190.00%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
Cloverdale Capital Management, LLC 324,722$6,170,0003.39%
ALPINE ASSOCIATES MANAGEMENT INC. 1,233,589$23,437,0000.77%
Beryl Capital Management LLC 220,189$4,184,0000.77%
BERKLEY W R CORP 109,601$2,082,0000.44%
WATER ISLAND CAPITAL LLC 514,970$9,784,0000.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 91,411$1,737,0000.22%
DELTEC ASSET MANAGEMENT LLC 50,000$950,0000.21%
Versor Investments LP 113,905$2,164,0000.21%
ALGERT GLOBAL LLC 14,774$281,0000.16%
Hillsdale Investment Management Inc. 92,941$1,766,0000.16%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders